Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Neurotrope, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R21.htm
10-Q - FORM 10-Q FOR 10-31-2012 - Neurotrope, Inc.form_10-q.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R18.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_31-2.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Neurotrope, Inc.ex_31-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_32-1.htm
v2.4.0.6
Statement of Cash Flows (USD $)
9 Months Ended 22 Months Ended
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2012
OPERATING ACTIVITIES      
Net Loss $ (10,057) $ (7,894) $ (25,312)
Changes in Operating Assets and Liabilities:      
Increase (decrease) in accounts payable and accrued liabilities 36 (2,950) 36
Increase (decrease) in notes payable 6,200    6,200
Net cash used in operating activities (3,821) (10,844) (3,821)
FINANCING ACTIVITIES      
Common stock issued for cash    13,000 21,000
Net cash provided by financing activities    13,000 21,000
INCREASE IN CASH AND CASH EQUIVALENTS (3,821) 2,156 1,924
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 5,745 8,000  
CASH AND CASH EQUIVALENTS AT END OF PERIOD 1,924 10,156 1,924
Cash paid for:      
Interest expense         
Income taxes